Therapeutics, drug discovery and life-science platforms, ranked by how many investors have backed each one.
Ranked by the number of distinct investors on record. Investor counts come from recorded rounds, so a company with few investors may simply be early rather than unbacked.
Tubulis
series bAgomab Therapeutics
series bMemo Therapeutics AG
acquiredMineralys Therapeutics
unknownRecursion
series c plusF2G
series bGenSight
unknownGrail
series c plusGreen City Solutions
series aHerantis Pharma
unknowniTeos Therapeutics
unknownNunaBio
seedThermosome
unknownABclonal
series c plusAmolyt Pharma
acquiredAscend
series bAvalyn Pharma
series c plusBenchling
series c plusBetter Dairy
seedBluejay Therapeutics
acquiredC 4 Therapeutics, USA
unknownCaris Life
series c plusElevateBio
unknownGenomics
series aHilleVax
series bLeyden Labs
series bNeosense
unknownNuritas
series bROME Therapeutics
acquiredSeqOne
series bSlingshot Biosciences
series aTailor Bio Ltd
seedTissium
series c plusTreeFrog Therapeutics
unknownViAqua
series a$IOTA
series aakouos
acquiredAltos Labs
unknownantiva biosciences
unknownAphea.Bio
series bAspen Neuroscience
series c plusAzafaros
series bBillionToOne
series aBioAge Labs
series c plusbit.bio
series bChromologics
unknownComplix
unknownCurve Therapeutics
series aElkedonia
series aElypta
series aGeltor
unknownGenerate Biomedicines
series c plusGenesis Molecular AI
unknownGuardant Health
unknownHealx
unknownHemotune
unknownImmunic Therapeutics
series c plusKAHR
series c plusMirum Pharmaceuticals
unknownMolecule
series bComputed across the whole tagged set, not just the companies listed above. Percentages are of the companies that have the field recorded, which is stated for each.
2,091 companies with a recorded country
1,300 companies with a recorded stage
The investors behind these companies are ranked on the biotech investor page, ordered by how many biotech companies each one has actually funded rather than by stated focus.